Back to search

Sweden· SE-20190211000150

Abriff 250 mikrogram/10 mikrogram/puff Inhalationsspray, suspension

A medicinal product containing fluticasone propionate + formoterol fumarate dihydrate, registered in Sweden by Mundipharma AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedAbriff 250 mikrogram/10 mikrogram/puf…ATC—REGISTER NO.SE-20190211000150PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Fluticasone Propionate + Formoterol Fumarate Dihydrate
Manufacturer
Mundipharma AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20190211000150

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluticasone propionate + formoterol fumarate dihydrate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone propionate + formoterol fumarate dihydrate products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Flutiform
  • Belgium · Flutiform
  • Bulgaria · Flutiform
  • Cyprus · Flutiform
  • Czechia · Flutiform
  • Germany · Flutiform
  • Denmark · Flutiform
  • Spain · Flutiform
  • Finland · Flutiform
  • France · Flutiform
  • United Kingdom (Northern Ireland) · Affera, Flutiform
  • Croatia · Flutiform
  • Ireland · Flutiform
  • Iceland · Flutiform
  • Italy · Abriff, Flutiformo
  • Luxembourg · Flutiform
  • Netherlands · Flutiform
  • Norway · Flutiform
  • Portugal · Flutiform
  • Slovenia · Flutiform
  • Slovakia · Flutiform

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd704f41-18f5-4baa-a508-fa9fe463583c
GET /v1/drugs/fd704f41-18f5-4baa-a508-fa9fe463583c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20190211000150",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190211000150",
  "product_doc_link": "https://docetp.mpa.se/LMF/Abriff%2C%20pressurised%20inhalation%2C%20suspension%2C%20ENG%20SmPC_09001bee807a0807.pdf"
}

See everything about fluticasone propionate + formoterol fumarate dihydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.